IP Library › Granted Patent US 10,961,577
Granted Patent B2
US 10,961,577 · App. 16/121,077 · Granted Mar 30, 2021

Methods and systems for assessing and/or quantifying sperm cell subpopulations bearing a specific genetic signature

Inventors: Elon Roti-Roti (Windsor, WI); Nicole Cray (Madison, WI); Matthias Wagner (Cambridge, MA); Michael Reid Botts (Deforest, WI)
Assignee: Genus plc
C12Q1/6879C12Q1/6841C12Q2600/124C12Q2600/16C12Q2600/166
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,961,577
App. No.
16/121,077
Granted
Mar 30, 2021
Kind
B2
Abstract

Technologies for assessing, quantifying and isolating sperm cell populations and/or subpopulations having specific genetic signatures are provided, as well as methods and systems to assess the efficacy of chromosomal differentiation processes. Compositions for identification and differentiation of X-chromosomes and Y-chromosomes in DNA are also provided.

Claims (40)

1. A method of assessing sex-skew in a population of sperm cells, the method comprising steps of:

detecting binding of a set of oligonucleotide agents to sperm DNA obtained from a sample of sperm cells, wherein the set includes:

a first oligonucleotide agent that selectively binds to an X-chromosome nucleic acid sequence comprising at least one sequence selected from the group consisting of SEQ ID NO: 4-6, 28-35, 222, and 845-847;

a second oligonucleotide agent that selectively binds to a Y-chromosome nucleic acid sequence comprising at least one sequence selected from the group consisting of SEQ ID: 7-9, 36-55, 767, 850-861, and 864-875; and

a third oligonucleotide agent that selectively binds to an autosomal chromosome nucleic acid sequence.

2. The method of claim 1 , further comprising isolating sperm DNA from a population of sperm cells from a semen sample.

3. The method of claim 2 , further comprising removing laser ablated sperm cells from said semen sample of sperm cells prior to said isolating sperm DNA.

4. The method of claim 1 , wherein said population of cells comprise an X-skewed sperm population.

5. The method of claim 1 , wherein said step of detecting comprises amplifying at least one of an X-chromosome tamet site, a Y-chromosome target site, and a housekeeping target site.

6. The method of claim 1 , wherein the first oligonucleotide agent that selectively binds to an X-chromosome nucleic acid sequence comprises:

a first primer;

a second primer; and

a probe.

7. The method of claim 1 , wherein the second oligonucleotide agent that selectively binds to a Y-chromosome nucleic acid sequence comprises:

a first primer;

a second primer; and

a probe.

8. The method of claim 7 , wherein said X-chromosome primer sequences comprise SEQ ID NOs: 4 and 5, and said probe sequence comprises SEQ ID NO: 6.

9. The method of claim 8 , wherein said Y-chromosome primer sequences comprise SEQ ID NOs: 7 and 8, and said probe sequence comprises SEQ ID NO: 9.

10. The method of claim 7 , wherein said probe includes a detectable label.

11. The method of claim 8 , wherein said probe includes a detectable label.

12. The method of claim 1 , wherein said third oligonucleotide agent comprises primer sequences comprising SEQ ID NOs: 1 and 2, and a probe sequence comprising SEQ ID NO: 3.

13. A kit for assessing the sex-skew in a population of cells, comprising:

a first oligonucleotide agent that selectively binds to an X-chromosome nucleic acid sequence comprising at least one sequence selected from the group consisting of SEQ ID NO: 4-6, 28-35, 222, and 845-847;

a second oligonucleotide agent that selectively binds to a Y-chromosome nucleic acid sequence comprising at least one sequence selected from the group consisting of SEQ ID: 7-9, 36-55, 767, 850-861, and 864-875; and

a third oligonucleotide agent that selectively binds to an autosomal chromosome nucleic acid sequence.

14. The kit of claim 13 , wherein:

said first nucleotide agent comprises oligonucleotide primer sequences SEQ ID NOs: 4 and 5, and oligonucleotide probe sequence SEQ ID NO: 6;

said second nucleotide agent comprises oligonucleotide primer sequences SEQ ID NOs:7 and 8, and oligonucleotide probe sequence SEQ ID NO: 9; and

said third nucleotide agent comprises oligonucleotide primer sequences SEQ ID NOs: 1 and 2, and oligonucleotide probe sequence SEQ ID NO: 3.

15. The kit of claim 13 , further comprising reagents and buffers for removing non-viable sperm cells.

16. The kit of claim 13 , further comprising reagents and buffers for isolating DNA from a sample of sperm cells.

17. The method of claim 1 , wherein said autosomal chromosome nucleic acid sequence is a glyceraldehyde 3-phosphate dehydrogenase (GAPDH) nucleotide sequence.

18. The method of claim 2 , wherein said semen sample is from Bos Taurus, Bos indicus, Bos bubalis, or hybrids thereof.

19. The method of claim 1 , wherein said detecting comprises performing multiplex ddPCR.

20. A method of assessing sex-skew in a population of sperm cells, the method comprising steps of:

detecting binding of a set of oligonucleotide agents to sperm DNA obtained from a sample of sperm cells, wherein the set includes:

a first oligonucleotide agent that selectively binds to an X-chromosome nucleic acid sequence comprising SEQ ID NOs: 4 and 5, and a probe sequence comprising SEQ ID NO: 6;

a second oligonucleotide agent that selectively binds to a Y-chromosome nucleic acid sequence comprising SEQ ID NOs: 7 and 8, and a probe sequence comprising SEQ ID NO: 9; and

a third oligonucleotide agent that selectively binds to an autosomal chromosome nucleic acid sequence wherein said detecting comprises performing multiplex ddPCR.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2021
From: GENUS PLC
To: ABS GLOBAL, INC.
Reel/Frame 055975/0885 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2018
From: ROTI-ROTI, ELON; CRAY, NICOLE; WAGNER, MATTHIAS; BOTTS, MICHAEL REID
To: GENUS PLC
Reel/Frame 047557/0059 →
Continuity (2)
Provisional Application 62553771 · Sep 1, 2017
Related Publication 20190071725A1 · Mar 7, 2019
Cited By (1)
US 12,258,630